Company Performance: Samsung Biologics' revenue, profits, and pipeline progress directly influence investor sentiment. Positive earnings reports or successful clinical trial outcomes typically increase the stock price.

Industry Trends: The overall health and growth prospects of the biopharmaceutical industry and contract manufacturing (CMO) sector impact Samsung Biologics. Positive industry reports can boost the stock.

Market Conditions: Broader economic factors, such as interest rates, inflation, and global economic growth, can affect investor risk appetite and overall market sentiment, influencing stock prices.

Regulatory Environment: Changes in regulations related to drug development, manufacturing, and pricing can affect Samsung Biologics' profitability and future prospects.

Competition: The competitive landscape, including the actions of rival CMOs, biosimilar manufacturers, and other pharmaceutical companies, can influence Samsung Biologics' market share and stock price.

Investor Sentiment: Investor confidence and overall market sentiment toward Samsung Biologics and the Korean stock market can drive demand for the stock.

Global Events: Global events, like pandemics or geopolitical instability, can affect supply chains, demand for healthcare products, and overall market volatility, influencing stock prices.